The Nasdaq-listed company says its Corexa pharmacy plans to fill prescriptions for eligible peptides once the FDA's interim policy takes effect.
Recap by typeshit. Full story at Yahoo Finance.
She talks with Annika Urban about combining GLP-1 treatment with behavioral coaching and telehealth care.
An opinion piece drawing on Sabrina Strings to tie GLP-1 culture, celebrity ads and Ozempic-friendly menus to class and belonging.
Oddo moved to DKK 305 and HSBC to DKK 280. Novo also shared a CagriSema subgroup analysis showing women lost 25% of body weight at 68 weeks.
MUSC Health suggests the familiar ABCs of heart health may change, with GLP-1 medications now part of cardiovascular prevention for some patients.
A French clip flags dry mouth and reflux in GLP-1 patients, plus a specific risk to watch for before sedation.
The approval covers MASH with F2 to F3 fibrosis, with semaglutide used alongside diet and exercise. A recap of an earlier decision rather than fresh news.
Loading…